Arcturus Therapeutics Holdings Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
12.00
0.05
(0.42%)
Volume:
262,114
52 week range:
11.60 - 45.00
Market Cap:
324.082M
Company Description:
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNar-CF program for cystic fibrosis lung disease. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines.